Centene Corporation (NYSE:CNC) fell by 11.1% last week, hitting an all-time low of $27.95 as investors grew cautious before its Q2 earnings report. Elevance Health’s 24.2% drop in net income and negative outlook also impacted CNC. S&P Global Ratings may downgrade CNC to junk status after it withdrew its 2025 earnings forecast due to revenue concerns from ACA plans. S&P cited concerns about CNC’s capital adequacy and business strength. While CNC has potential, some AI stocks may offer better returns with less risk. Investors seeking cheap AI stocks can explore Insider Monkey’s report on the best short-term AI stock.

Read more at Yahoo Finance: Centene (CNC) Falls 11.1% on Investor Caution Ahead of Q2